FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称CAMIDANLUMAB
异名/同义词CAMIDANLUMAB
CAMIDANLUMAB [INN]
CAMIDANLUMAB [USAN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR .ALPHA. CHAIN)(HUMAN HUMAX-TAC HEAVY CHAIN), DISULFIDE WITH HUMAN HUMAX-TAC LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA (TAC ANTIGEN, P55, CD25 ANTIGEN)), HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-445) (HOMO SAPIENS VH (IGHV1-69*02 (95%) (IGHD)-IGHJ4*01 (93%)) (8.8.8) (1-115) -HOMO SAPIENS IGHG1*03 (116-445)), (218-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-20*01 (99%) IGKJ4*01)(6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214'))DIMER (224-224'':227-227'')-BISDISULFIDE
CAS登记号921618-45-3
物质唯一标识(Unique Ingredient Identifier)UP9K666A04
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System